Healthcare -
Biotechnology - NASDAQ - US
$ 14.49
0.485 %
$ 92.1 M
Market Cap
-2.1
P/E
Price Target
Average
145.00%
Revenue Forecast
Estimate
246.89%
EBIT
Estimate
--37.78%
Net Income
Estimate
15.71%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Assembly Biosciences, Inc.
Wall Street analysts predict an average 1-year price target for ASMB of $35.5 , with forecasts ranging from
a
low of
$35 to a high of $36 .
ASMB Lowest Price Target
Wall Street Target
35 USD
141.55%
ASMB Average Price Target
Wall Street Target
35.5 USD
145.00%
ASMB Highest Price Target
Wall Street Target
36 USD
148.45%
REVENUE FORECAST
Revenue Forecast Chart ASMB
EBIT FORECAST
EBIT Forecast Chart ASMB
NET INCOME FORECAST
Net Income Chart ASMB